Sheaff Brock Investment Advisors, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Sheaff Brock Investment Advisors, LLC
- $1.07 Billion
- Q2 2024
A detailed history of Sheaff Brock Investment Advisors, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Sheaff Brock Investment Advisors, LLC holds 3,500 shares of MDGL stock, worth $743,505. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,500
Previous 3,600
2.78%
Holding current value
$743,505
Previous $961,000
1.98%
% of portfolio
0.09%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding MDGL
# of Institutions
298Shares Held
22MCall Options Held
757KPut Options Held
370K-
Janus Henderson Group PLC London, X02.49MShares$528 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.06MShares$437 Million7.86% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$419 Million7.35% of portfolio
-
Rtw Investments, LP New York, NY1.92MShares$407 Million8.96% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.85MShares$393 Million39.74% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $3.63B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...